Back
Dermata Therapeutics, Inc. 10K Form
Sell
12
DRMA
Dermata Therapeutics, Inc.
Last Price:
$2.14
Seasonality Move:
-34.61%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive DRMA News And Ratings
See the #1 stock for the next 7 days that we like better than DRMA
DRMA Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-1.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.69 |
| Price / Book: | 0.6 |
Profitability
| EPS (TTM): | -16.26730 |
|---|---|
| Net Income (TTM): | $-8.8M |
| Gross Margin: | $0 |
| Return on Equity: | -190.86% |
| Return on Assets: | -138.51% |
Dermata Therapeutics, Inc. Earnings Forecast
Key Dermata Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 6 years have been positive in 3 years.
Dermata Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | DRMA |
| Website: | dermatarx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 4.56 |
| Quick Ratio: | 4.2 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
DRMA Technical Analysis vs Fundamental Analysis
Sell
12
Dermata Therapeutics, Inc. (DRMA)
is a Sell
Is Dermata Therapeutics, Inc. a Buy or a Sell?
-
Dermata Therapeutics, Inc. stock is rated a SellThe current Dermata Therapeutics, Inc. [DRMA] share price is $2.30. The Score for DRMA is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.